Triple-action GLP-1/GIP/Glucagon agonist
Everything You Need to Know
Retatrutide is the newest breakthrough in metabolic peptides. While Tirzepatide works on two receptors, Retatrutide works on THREE - adding glucagon receptor activation for enhanced fat burning and energy expenditure.
**What makes it special?** The glucagon component helps your body burn stored fat more efficiently, potentially leading to greater weight loss results than dual-agonist peptides.
Key Benefits
- Triple-receptor activation for enhanced effects
- May provide greater weight loss than dual-agonists
- Increases fat burning through glucagon activation
- Once-weekly dosing
Ideal For
- Those who have plateaued on other GLP-1 agonists
- People seeking cutting-edge metabolic support
- Adults with significant weight loss goals
How It Works
Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously. This triple action reduces appetite, improves insulin sensitivity, AND increases fat burning.
Who Should NOT Use
Do NOT use if you are: pregnant or breastfeeding, have severe allergies to injections, undergoing active cancer treatment, have uncontrolled heart/kidney/liver disease, or currently hospitalized.
Talk to Your Doctor
We always recommend consulting with a healthcare provider before starting any wellness protocol. Regular check-ups and lab work help you track your progress safely.